BASF has signed a letter of intent with China-based Anhui Huaheng Biotechnology (AHB) to establish a joint venture
(JV) for the production of L-alanine.The JV partnership will employ technology developed and already operated by
"AHB is engaged in the research, development, and marketing of amino acid products, and is one of the major
L-alanine producers in China."Based in the Shuangfeng Economic Development Zone, Hefei, China, AHB is
engaged in the research, development, and marketing of amino acid products, and is one of the major L-alanine
producers in China.
AHB produces alanine using the fermentation method and exports its products to countries including the US,
Canada,Germany, Japan and South Korea.The JV will serve BASF's requirements and allow AHB to cater to the
pharmaceutical,fine-chemical, food and beverage industries.BASF said in a statement: "Both companies will
continue to pursue joint cooperation to take advantage of economies of scale and the complementary expertise
each has in their respective areas."
BASF has made a series of investments in the Asia-Pacific region.Last month, the company expanded its mobile
emissions catalysts production in Shanghai and announced plans to boost tertiary Butylamine production at its
complex in Nanjing Chemical Industry Park, China.
The German giant, which also opened a chemical complex in the state of Gujarat, India, has cut its chemical
production targets for this year and 2015, expecting a 4% rise in production in the current and next fiscal years.